PRKN and neuroblastoma: Ubiquitination of Nup358 by Parkin leads to its degradation by the ubiquitin-proteasome system in human neuroblastoma cells, implying that Parkin mutations may compromise Nup358 degradation, causing its accumulation and impairing NCT [174].